| Literature DB >> 28954220 |
Yang Zhou1, Li Wang1, Ziqing Liu1, Sahar Alimohamadi1, Chaoying Yin1, Jiandong Liu1, Li Qian2.
Abstract
Cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) or directly reprogrammed from non-myocytes (induced cardiomyocytes [iCMs]) are promising sources for heart regeneration or disease modeling. However, the similarities and differences between iPSC-CMs and iCMs are still unknown. Here, we performed transcriptome analyses of beating iPSC-CMs and iCMs generated from cardiac fibroblasts (CFs) of the same origin. Although both iPSC-CMs and iCMs establish CM-like molecular features globally, iPSC-CMs exhibit a relatively hyperdynamic epigenetic status, whereas iCMs exhibit a maturation status that more closely resembles that of adult CMs. Based on gene expression of metabolic enzymes, iPSC-CMs primarily employ glycolysis, whereas iCMs utilize fatty acid oxidation as the main pathway. Importantly, iPSC-CMs and iCMs exhibit different cell-cycle status, alteration of which influenced their maturation. Therefore, our study provides a foundation for understanding the pros and cons of different reprogramming approaches.Entities:
Keywords: cardiac differentiation; cardiac reprogramming; cardiomyocyte; gene expression profiling; iCM; iPSC
Mesh:
Year: 2017 PMID: 28954220 PMCID: PMC5659840 DOI: 10.1016/j.celrep.2017.09.005
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423